Skip to main content
MMS
NYSE Trade & Services

Maximus 10-K: FY2026 EPS $7.27 GAAP / $8.24 Adjusted, FY2027 Margin Guidance Set

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Business Services Stocks · Industrial
Sentiment info
Negative
Importance info
7
Price
$61.97
Mkt Cap
$3.255B
52W Low
$51.036
52W High
$100
52W Position info
21% above low
Off High info
38% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

MMS sits 21% above its 52-week low of $51.036.

Summary

Maximus closed FY2026 with adjusted EPS of $8.24 on $5.23 billion of revenue, but guided FY2027 federal margins down to 14%-15% after a VA contract modification removed about $25 million of quarterly incentive revenue.


Key Events · Earnings and Guidance · MMS

  • FY2026 Results: Margin Expansion Lifts EPS

    Revenue fell 3.7% to $5,230,792 thousand, but operating margin rose to 11.7% from 9.7%, lifting net income to $392,604 thousand and diluted EPS to $7.27 from $5.51; adjusted diluted EPS was $8.24 versus $7.36.

  • VA Incentive Pause Hits FY2027 Guidance

    A fourth-quarter modification to the VA medical disability exam contract paused incentive payments that previously provided approximately $25 million of revenue and profit quarterly; management assumes no incentives in FY2027 and guides U.S. Federal Services operating margin to 14%-15% and U.S. Services to about 10%.

  • Backlog Falls to $13.8 Billion

    Total backlog declined to $13,761 million from $15,327 million, driven by U.S. Federal Services falling to $6,895 million from $9,780 million, partly offset by U.S. Services rising to $5,431 million from $3,916 million.

  • Cash Flow Squeezed by Collection Delays

    Operating cash flow dropped to $112,392 thousand from $429,372 thousand as DSO rose to 93 days from 62; more than $330 million of past-due invoices from a single large federal customer were collected after September 30.


Analysis · MMS · Trade & Services

The annual report puts audited numbers behind the morning's headlines and, more importantly, lays out what FY2027 looks like after the Agile Defense deal. Revenue fell 3.7% to $5.23 billion, but cost cuts and technology use lifted operating margin to 11.7% from 9.7%, so net income rose to $392.6 million ($7.27 diluted) from $319.0 million. The problem is forward-looking: a VA contract modification paused incentive payments that had been worth about $25 million of revenue and profit each quarter, and management assumes none of that in FY2027, guiding U.S. Federal Services margin to 14%-15% and U.S. Services to about 10%. Backlog dropped to $13.8 billion from $15.3 billion, with the federal segment down to $6.9 billion from $9.8 billion. Cash generation was the weak spot — operating cash flow of $112.4 million versus $429.4 million a year ago as days sales outstanding stretched to 93 from 62, though over $330 million of past-due federal invoices were collected after year-end. Leverage sits at 1.77x with $1.61 billion of debt, and management still plans roughly $200 million of buybacks in FY2027 while integrating the $660 million Agile Defense acquisition funded with $295 million of new term loans.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MMS was trading at $61.97 on NYSE in the Trade & Services sector, with a market capitalization of approximately $3.3B. The 52-week trading range was $51.04 to $100.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MMS - Latest Insights

MMS
Nov 19, 2026, 8:17 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $65.60
Real-time Price: $61.99 info
Change: -$3.61 (-6%) info
Market Cap: $3.249B info
MMS
Nov 19, 2026, 7:50 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $65.60
Real-time Price: $61.99 info
Change: -$3.61 (-6%) info
Market Cap: $3.249B info
MMS
Nov 19, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $65.26
Real-time Price: $61.99 info
Change: -$3.27 (-5%) info
Market Cap: $3.249B info
MMS
Oct 20, 2026, 7:25 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $61.33
Real-time Price: $61.99 info
Change: +$0.660 (+1%) info
Market Cap: $3.249B info
MMS
Oct 19, 2026, 5:00 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $61.33
Real-time Price: $61.99 info
Change: +$0.660 (+1%) info
Market Cap: $3.249B info